Sarepta Therapeutics Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

57.67%

Market Cap

11.12 Bil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-6.32 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE14 G0 Units
PRICE DETERMINATION TIME06/03/2026 / 09:55:50 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW14.2213.84
PREV. DAY'S PRICE13.9 (06/02)
CHANGE DAY BEFORE
+0.10
0.72 %
52 WEEK HIGH / LOW38.01 (06/09)8.98 (07/24)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE0.812.97-6.322.16-5.37
DIVIDENDS PER SHARE0.000.000.000.000.00
DIVIDEND YIELD IN %--0.00 %0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO18.215.00-52.00-
PRICE - BOOK RATIO--1.987.7110.52
PRICE - SALES RATIO--0.986.907.17
PRICE - CASH FLOW RATIO-----
Further Key Figures

Master Data

WKN
A1J1BH
ISIN
US8036071004
SYMBOL
AB3A
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Sarepta Therapeutics
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
93.86 Mil.
MARKET CAPITALISATION
11.12 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-2.37 %
-21.56 %
2.83 %
-20.00 %
-57.67 %
-87.98 %
-76.94 %
-23.14 %
HIGH15.5619.9220.5020.5038.01155.95155.9520.50
LOW13.8213.8213.4413.428.988.988.9813.42
Dividend
per share
Sarepta Therapeutics does not deliver dividend information

Company profile

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.